Guanabenz degradation products and stability assay

DOI: 10.1002/jps.2600680824

Source and publish data:

Journal of Pharmaceutical Sciences p. 1010 - 1012 (1979)

Update date:2022-08-04

Topics:

Authors:

Shearer Shearer

DeAngelis

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1002/jps.2600680824

Full text of DOI:10.1002/jps.2600680824

Products guided by the article

Product name:(Z)-Guanabenz

Cas No:60329-05-7

R&D Labs maybe for 60329-05-7

AURORA CHEMICAL CO., LTD

Contact:86-532-68629711 13780605697

Address:NO 220 YANAN 3 ROAD,(POST ADMINISTRATION BUILDING),QINGDAO,CHINA
Chengdu Boon Stream Chemical Industry Co.,Ltd.

Contact:+86-28-83156758

Address:No.859,Dongzikou Road,Jinniu District,Chengdu,Sichuan,P.R.China
Jiaxing Taixin Pharmaceutical Chemical Co., Ltd

Contact:0573-82613601

Address:Chemical Park, Jiaxing, Zhejiang, China
Hangzhou Mole's Science & Technology Co.,Ltd.(expird)

Contact:+86-571-56880228

Address:15F Guodu development Building, NO.182 Zhaohui Road
Shenyang Mole pharmaceutical Technology Development Co.,Ltd

Contact:+86-24-31204918/13889278616

Address:No.44, wanliutang road, shenhe District of Shenyang

Relevant to this article

Efficient and short route for the regioselective synthesis of highly substituted, angularly fused furano-, pyrano-, and pyrrolocoumarin/quinolone derivatives by metal-mediated cyclization

Doi:10.1080/00397910903219559
(2010)
Aminotetralins as narcotic antagonists. 2. Synthesis and opiate-related activity of 1-phenyl-3-aminotetralins

Doi:10.1021/jm00345a005
(1982)
Magnetic Relaxation Studies on Trigonal Bipyramidal Cobalt(II) Complexes

Doi:10.1002/asia.201901511
(2020)
Medicinally Relevant Modification of the Isoquinoline-1,3-dione Scaffold via Metal-Free Arylation and Fluorination of Diazo Homophthalimides?-in Bronsted Acids

Doi:10.1055/s-0037-1611882
(2019)
Light-Induced Tetrazole-Quinone 1,3-Dipolar Cycloadditions

Doi:10.1002/chem.201904138
(2019)
Stereoselective syntheses of rolliniastatin 1, rollimembrin, and membranacin

Doi:10.1021/ja0526867
(2005)

Article Doi